Biotech Showcase™, produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives during the course of one of the industry's largest annual healthcare investor conferences.
On Wednesday, January 10, 2018, 9:00-10:00 am, CRI's CEO and Director of Scientific Affairs, Dr. Jill O’Donnell-Tormey, is a panelist on “IO on the move: New targets, new trends, new combinations”.
The conference will take place at Hilton Union Square, 333 O'Farrell St, San Francisco, CA 94102.
Follow the event hashtag #BTS18.
Photo by Artur Łuczka on Unsplash.
